Novel 7-azaoxindole derivative with GAS6/AXL inhibitory activity disclosed
April 5, 2023
Researchers from Yeungnam University and collaborators presented the discovery and preclinical evaluation of novel 7-azaoxindole derivatives for their antitumor activity.